VNDA - バンダ・ファ―マシュ―ティカルズ （Vanda Pharmaceuticals Inc.） バンダ・ファ―マシュ―ティカルズVNDAのチャート
VNDAの企業情報
| symbol | VNDA |
|---|---|
| 会社名 | Vanda Pharmaceuticals Inc （バンダ・ファ―マシュ―ティカルズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 バンダ・ファーマシューティカルズ（Vanda Pharmaceuticals Inc.）は生物医薬品会社である。同社は、満たされていない医療ニーズに対応する治療法の開発・商品化を行う。同社の製品ポートフォリオには、HETLIOZ（tasimelteon）、Fanapt（iloperidone）、Tradipitant（VLY-686）、Trichostatin AおよびAQW051がある。同社は非24時間睡眠覚醒障害（24歳未満）の治療にHETLIOZを提供する。HETLIOZは、Pediatric Non-24、Jet Lag DisorderおよびSmith-Magenis症候群の治療用の臨床開発中である。同社は統合失調症の治療用のFanaptを提供する。Fanaptは、多様な他の障害において有用性がある。Tradipitantは、小分子ニューロキニン-1受容体（NK-1R）アンタゴニストであり、アトピー性皮膚炎における慢性掻痒の治療のための臨床開発中である。トリコスタチンAは、小分子ヒストンデアセチラーゼ（HDAC）阻害剤である。AQW051は、第II相アルファ-7ニコチン性アセチルコリン受容体部分アゴニストである。AQW051は、中枢神経系障害の治療に適応する。 バンダ・ファ―マシュ―ティカルズは、米国のバイオ医薬品会社。中枢神経系障害の治療用の薬品を開発、商業化する。主要な製品には、24時間睡眠覚醒障害の治療用に「HETLIOZ」、統合失調症の治療用に「Fanapt」、アトピ―性皮膚炎の治療用に小分子ニュ―ロキニン-1受容体拮抗薬「VLY-686」などがある。 vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients. |
| 本社所在地 | 2200 Pennsylvania Avenue N.W. Suite 300 E Washington DC 20037 USA |
| 代表者氏名 | H. Thomas Watkins H.トーマス・ワトキンス |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 202-734-3400 |
| 設立年月日 | 37561 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2006年 |
| 従業員数 | 273人 |
| url | www.vandapharma.com |
| nasdaq_url | https://www.nasdaq.com/symbol/vnda |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 2.28300 |
| 終値（lastsale） | 23 |
| 時価総額（marketcap） | 1204727235 |
| 時価総額 | 時価総額（百万ドル） 1123.539 |
| 売上高 | 売上高（百万ドル） 176.55400 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 892.32300 |
| 当期純利益 | 当期純利益（百万ドル） 1.28900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Vanda Pharmaceuticals Inc. revenues increased 14% to $90.9M. Net income totaled $7.7M vs. loss of $9.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Selling General and administrative - decrease of 14% to $49.5M (expense) Other income increase from $677K to $1.4M (income). |
VNDAのテクニカル分析
VNDAのニュース
Vanda Pharmaceuticals: Uncharted Waters Ahead 2023/06/06 12:07:09 Seeking Alpha
Vanda Pharmaceuticals has fallen largely due to legal setbacks around its primary approved drug HETLIOZ. Find out why VNDA stock is a Hold.
Vanda Pharmaceuticals Announces Participation in the Jefferies 2023 Global Healthcare Conference 2023/06/05 11:00:00 PR Newswire
WASHINGTON, June 5, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies 2023 Global Healthcare Conference in New York City on Friday, June 9, 2023. A corporate presentation is scheduled for 12:15 p.m….
Mirae Asset Global Investments Co. Ltd. Purchases 3,374 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) 2023/06/05 10:45:36 The AM Reporter
Mirae Asset Global Investments Co. Ltd. boosted its stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) by 13.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,592 shares of the biopharmaceutical company’s stock after purchasing an additional 3,374 shares […]
Vanda Pharmaceuticals (NASDAQ:VNDA) Downgraded by StockNews.com to “Buy” 2023/06/02 07:52:44 EIN News Pharmaceuticals
… Funds Weigh In On Vanda Pharmaceuticals Several institutional investors and … institutional investors. About Vanda Pharmaceuticals (Get Rating) Vanda Pharmaceuticals , Inc engages in … '' ratings for Vanda Pharmaceuticals and related companies with MarketBeat …
Vanda Pharmaceuticals Inc. (VNDA) Q1 2023 Earnings Call Transcript 2023/05/03 22:19:05 Seeking Alpha
Vanda Pharmaceuticals Inc. (NASDAQ:NASDAQ:VNDA) Q1 2023 Earnings Conference Call May 3, 2023 4:30 AM ETCompany ParticipantsKevin Moran - CFOMihael Polymeropoulos - President, CEO and…
Vanda Pharmaceuticals wins lawsuit against FDA 2023/03/30 19:26:30 Business Journals
The company had sued federal regulators as part of its yearslong quest to bring a jet lag treatment to market.
Vanda wins FOIA litigation against FDA regarding Hetlioz for jet lag 2023/03/28 19:20:09 Seeking Alpha
A judge has ruled that Vanda Pharmaceuticals should have access to documents related the the FDA''s review of a supplemental jet lag indication for Hetlioz. Read more.
Vanda Pharma SVP Trades Company''s Stock 2023/03/07 15:03:06 Benzinga
Joakim Wijkstrom , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Wijkstrom sold 11,833 shares of Vanda Pharma . The total transaction amounted to $74,116. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com
Vanda Pharma Recent Insider Activity 2023/03/07 15:02:59 Benzinga
Kevin Patrick Moran , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Moran sold 13,934 shares of Vanda Pharma . The total transaction amounted to $87,344. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com
Massive Insider Trade At Vanda Pharma 2023/03/07 15:02:53 Benzinga
Gunther Birznieks , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Birznieks sold 16,777 shares of Vanda Pharma . The total transaction amounted to $104,583. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com
Vanda Pharmaceuticals wins lawsuit against FDA 2023/03/30 19:26:30 Business Journals
The company had sued federal regulators as part of its yearslong quest to bring a jet lag treatment to market.
Vanda wins FOIA litigation against FDA regarding Hetlioz for jet lag 2023/03/28 19:20:09 Seeking Alpha
A judge has ruled that Vanda Pharmaceuticals should have access to documents related the the FDA''s review of a supplemental jet lag indication for Hetlioz. Read more.
Vanda Pharma SVP Trades Company''s Stock 2023/03/07 15:03:06 Benzinga
Joakim Wijkstrom , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Wijkstrom sold 11,833 shares of Vanda Pharma . The total transaction amounted to $74,116. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com
Vanda Pharma Recent Insider Activity 2023/03/07 15:02:59 Benzinga
Kevin Patrick Moran , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Moran sold 13,934 shares of Vanda Pharma . The total transaction amounted to $87,344. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com
Massive Insider Trade At Vanda Pharma 2023/03/07 15:02:53 Benzinga
Gunther Birznieks , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Birznieks sold 16,777 shares of Vanda Pharma . The total transaction amounted to $104,583. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com